
Volibose GM 2mg/500mg/0.2mg Tablet
Marketer
Tesla Labs Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Volibose GM 2mg/500mg/0.2mg Tablet
Diabetic patients with type 2 diabetes mellitus may benefit from Glycemic Control Tablets (GCT), a triple-combination anti-diabetic medication. This formulation aids in blood glucose regulation. GCT should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on your glycemic response. Continuous GCT use is crucial, even with controlled blood sugar, as abrupt cessation can elevate blood glucose, risking complications such as nephropathy, retinopathy, neuropathy, and limb loss. A comprehensive diabetes management plan encompassing diet, exercise, and weight management, as directed by your doctor, is essential. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are crucial for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. GCT is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women must consult their physician before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Uses of Volibose GM 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Volibose GM 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Volibose GM 2mg/500mg/0.2mg tablets on an empty stomach.
Common Side effects of Volibose GM 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Volibose GM 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Volibose GM 2mg/500mg/0.2mg tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Volibose GM 2mg/500mg/0.2mg Tablet works:
Each Volibose GM tablet (2mg/500mg/0.2mg) contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Volibose GM 2mg/500mg/0.2mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Volibose GM 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Volibose GM 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Volibose GM 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, its use is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should use Volibose GM 2mg/500mg/0.2mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. A reduced starting dose is typically employed for patients with mild to moderate liver disease; the medication is unsuitable for those with severe liver dysfunction.
What if you forget to take Volibose GM 2mg/500mg/0.2mg Tablet :
Should you forget a Volibose GM 2mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Volibose GM 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
